Abstract
Acquired angioedema due to C1 inhibitor deficiency (C1-INH-AAE) is a very rare disease compared to Hereditary angioedema (HAE). There is a need for an updated characterisation of patients with C1-INH-AAE to understand the disease pathogenesis and optimise treatment. We describe the disease burden, long term prophylaxis (LTP) and C1-INH-AAE-associated diseases in a multicentre UK cohort.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
